Stock listing

NG9 Stock Price, News, Filings & Events — Neogenomics, Inc.

Selected listing: NG9 · DUS · EUR · DE

The selected listing NG9:DUS represents Neogenomics, Inc., a leading provider of cancer-focused genetic testing services. The company specializes in advanced diagnostics and personalized medicine, offering a range of tests to support cancer treatment decisions. Recent news highlights their ongoing commitment to innovation in the oncology space, with updates on new test offerings and partnerships. Investors can find relevant filings and upcoming events that may impact the company's performance in the market.